Anbio Biotechnology (NNNN) Current Assets (2023 - 2025)

Anbio Biotechnology (NNNN) has 3 years of Current Assets data on file, last reported at $30.2 million in Q4 2025.

• On a quarterly basis, Current Assets rose 63.17% year-over-year to $30.2 million in Q4 2025; TTM through Dec 2025 was $30.2 million, a 63.17% increase from a year earlier, with the FY2025 full-year figure at $30.2 million, up 63.17% from the prior year.
• Current Assets for Q4 2025 stood at $30.2 million, down from $27680.6 billion in the prior quarter.
• Over the last five years, Current Assets for NNNN reached as high as $27680.6 billion in Q2 2025 and fell as low as $15.7 million in Q4 2023.
• Historically, Current Assets has averaged $6920.2 billion across 3 years, with a median of $24.4 million in 2024.
• Across the five-year window, Current Assets grew 17.68% in 2024 and surged 63.17% in 2025, its largest moves.
• Year by year, Current Assets stood at $15.7 million in 2023, then gained by 17.68% to $18.5 million in 2024, then jumped by 63.17% to $30.2 million in 2025.
• Per Business Quant data, the three most recent Current Assets figures were $30.2 million in Q4 2025, $27680.6 billion in Q2 2025, and $18.5 million in Q4 2024.